FORMULARY DECISION
Sitagliptin + Metformin : Janumet
492/08 : Type 2 diabetes. SMC restriction: restricted to use in patients for whom a combination of sitagliptin and metformin is an appropriate choice of therapy and only when the addition of sulphonyl...